Resilience Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8


  • Latest Deal Type
  • Out of Business

Resilience Therapeutics General Information


Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions including PTSD and Social Anxiety Disorder. The company is focused on developing therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress-Related Disorders, providing medical practitioners with first-in-class therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Corporate Office
  • Boston, MA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resilience Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 31-Dec-2021 00.000 Completed Out of Business
2. Seed Round 03-Mar-2016 00000 00.000 Completed Generating Revenue
1. Seed Round 30-Jul-2015 $2.92M $2.92M 00.00 Completed Generating Revenue
To view Resilience Therapeutics’s complete valuation and funding history, request access »

Resilience Therapeutics Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Resilience Therapeutics’s complete cap table history, request access »

Resilience Therapeutics Comparisons

HQ Location
Total Raised
Post Valuation
Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditi
Drug Discovery
Boston, MA
8 As of 2016
00000000 00 00.000


ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
Burlington, MA
0 As of 0000
000000000 00000


adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
0000 000000000
Clarksville, MD
0 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resilience Therapeutics Competitors (41)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Minerva Neurosciences Formerly VC-backed Burlington, MA 0 00000 000000000 00000
NeuroNascent Venture Capital-Backed Clarksville, MD 0 00.000 00000000000
Bolden Therapeutics Venture Capital-Backed Providence, RI 0 00.00 000000000 00.00
Neurogene Formerly VC-backed New York, NY 00 00000 000000000 00000
TiGenix Formerly VC-backed Leuven, Belgium 00 00000 000000&0 00000
You’re viewing 5 of 41 competitors. Get the full list »

Resilience Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resilience Therapeutics FAQs

  • When was Resilience Therapeutics founded?

    Resilience Therapeutics was founded in 2015.

  • Who is the founder of Resilience Therapeutics?

    Jeffrey Sabados, Brad Geddes Ph.D, Jeff Saunders Ph.D, and Retsina Meyer Ph.D are the founders of Resilience Therapeutics.

  • Where is Resilience Therapeutics headquartered?

    Resilience Therapeutics is headquartered in Boston, MA.

  • What is the size of Resilience Therapeutics?

    Resilience Therapeutics has 8 total employees.

  • What industry is Resilience Therapeutics in?

    Resilience Therapeutics’s primary industry is Drug Discovery.

  • Is Resilience Therapeutics a private or public company?

    Resilience Therapeutics is a Private company.

  • What is Resilience Therapeutics’s current revenue?

    The current revenue for Resilience Therapeutics is 000000.

  • How much funding has Resilience Therapeutics raised over time?

    Resilience Therapeutics has raised $3.42M.

  • Who are Resilience Therapeutics’s competitors?

    Minerva Neurosciences, NeuroNascent, Bolden Therapeutics, Neurogene, and TiGenix are some of the 41 competitors of Resilience Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »